Effects of ethanol intake on lipoproteins.

Current Atherosclerosis Reports
Eliot A Brinton

Abstract

These review discusses the effects of ethanol on lipoprotein levels and function as related to atherosclerosis and cardiovascular disease (CVD), with special emphasis on recent publications. Ethanol's effects on high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), triglycerides (TG), and other CVD risk factors recently have been explored. Other new data address genetic and demographic predictors and mechanisms of these responses. Not surprisingly, the results of some recent studies corroborate, whereas others differ from, earlier seemingly well-established findings. Prior and recent evidence shows favorable changes in HDL, other CVD risk factors, and CVD event rates with moderate, regular ethanol intake, and recent publications have explored the mechanisms of this relationship. Application of these findings in clinical practice remains problematic, however, due to the lack of randomized, controlled clinical trials of ethanol and due to the potential hazards of ethanol consumption.

References

Jan 15, 2000·Journal of the American College of Cardiology·J M GazianoJ E Buring
Nov 25, 2000·Metabolism: Clinical and Experimental·M N RaoM R Lakshman
Feb 15, 2001·Current Opinion in Lipidology·A van Tol, H F Hendriks
Jul 18, 2002·Critical Reviews in Clinical Laboratory Sciences·Minna L HannukselaMarkku J Savolainen
Jan 10, 2003·The New England Journal of Medicine·Kenneth J MukamalEric B Rimm
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·H D Sesso
Mar 10, 2004·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Minna L HannukselaMarkku J Savolainen
Apr 22, 2004·Alcoholism, Clinical and Experimental Research·Aafje SierksmaHenk F J Hendriks
Jul 3, 2004·Journal of Lipid Research·J W J BeulensH F J Hendriks
Nov 6, 2004·Current Opinion in Lipidology·Joseph M Li, Kenneth J Mukamal
Dec 7, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Joline W J BeulensHenk F J Hendriks
Feb 20, 2008·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·I Wakabayashi
Mar 20, 2008·American Journal of Physiology. Endocrinology and Metabolism·Margaret Sozio, David W Crabb
May 24, 2008·Alcoholism, Clinical and Experimental Research·Sanna M MäkeläMinna L Hannuksela
Aug 16, 2008·Metabolism: Clinical and Experimental·Hilda J I de JongJohanna M Geleijnse
Nov 27, 2008·Alcoholism, Clinical and Experimental Research·Marja Katriina Liisanantti, Markku Juhani Savolainen
Jan 27, 2009·The American Journal of Cardiology·Maryline FoersterNicolas Rodondi
Apr 2, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ichiro Wakabayashi, Klaus Groschner
Aug 22, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·E PerissinottoUNKNOWN ILSA Working Group
Sep 1, 2009·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Luc DjousséPhilip A Wolf
Dec 25, 2009·Circulation. Cardiovascular Genetics·Janne S TolstrupBørge G Nordestgaard
Jan 5, 2010·Metabolism: Clinical and Experimental·Ichiro Wakabayashi, Klaus Groschner
Jan 20, 2010·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Andreia OliveiraCarla Lopes
Mar 27, 2010·Journal of the American College of Cardiology·Kenneth J MukamalRosalind A Breslow
May 1, 2010·Atherosclerosis·Pedro Marques-VidalPeter Vollenweider
Jul 10, 2010·Current Opinion in Lipidology·Eliot A Brinton
Sep 20, 2011·Lancet·Cordelia ColtartRichard Thompson

❮ Previous
Next ❯

Citations

May 24, 2013·Lipids in Health and Disease·Elisabet SöderströmJohan Hultdin
Jun 5, 2014·Journal of Clinical Biochemistry and Nutrition·Alexandr ParlesakChristian Schäfer
Dec 29, 2013·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·K SchillerJ Kröger
May 13, 2014·Molecular Aspects of Medicine·Huifen WangAlice H Lichtenstein
May 29, 2014·The British Journal of Nutrition·Noora KanervaSatu Männistö
Jun 12, 2012·Vascular Pharmacology·Marika MassaroRaffaele De Caterina
Oct 16, 2015·Environmental Health and Preventive Medicine·Sei HaradaMasaru Tomita
Aug 9, 2016·International Journal of Epidemiology·Peter WürtzDavid A Leon
Sep 20, 2016·PloS One·Bruna Angelo VieiraBruce Bartholow Duncan
Oct 18, 2016·The Medical Clinics of North America·Janet M de JesusRobert H Eckel
Nov 18, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Sander De BruyneJoris R Delanghe
Dec 19, 2012·Circulation. Cardiovascular Genetics·Daniel BosMeike W Vernooij
Nov 14, 2018·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Meegan JusticeMee Young Hong
May 15, 2013·Expert Review of Medical Devices·Paul D Williams, Rob Whitbourn
Dec 20, 2013·The American Journal of Clinical Nutrition·Monica L BertoiaCharles B Eaton
Feb 11, 2014·Expert Review of Cardiovascular Therapy·Jing PangGerald F Watts
Mar 29, 2014·Journal of Cardiopulmonary Rehabilitation and Prevention·Chisa MatsumotoHoward D Sesso
May 20, 2017·Current Medicinal Chemistry·Luca LiberaleFederico Carbone
Jan 31, 2019·American Journal of Epidemiology·Paul S de VriesAlanna C Morrison
Mar 21, 2013·Current Opinion in Lipidology·Boudewijn KlopManuel Castro Cabezas
Nov 25, 2016·BioMed Research International·Mariangela RondanelliSimone Perna
Feb 22, 2017·The British Journal of Nutrition·Aila J AholaPer-Henrik Groop
Oct 21, 2020·Advanced Drug Delivery Reviews·Sumra NazirEmiel P C van der Vorst
Mar 8, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Tomasz Szkudelski, Katarzyna Szkudelska

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.